Research programme: VCAM/VLA-4 inhibitors - Kaken
Alternative Names: Cell adhesion inhibitors research programme - Kaken; Research programme: cell adhesion inhibitors - Kaken; VCAM/VLA-4 antagonists research programme - KakenLatest Information Update: 24 Feb 2009
At a glance
- Originator Kaken Pharmaceutical
- Class
- Mechanism of Action Integrin alpha4beta1 antagonists; Vascular cell adhesion molecule inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Asthma; Inflammation
Most Recent Events
- 02 Sep 2004 This programme is still in active development
- 28 May 2001 Preclinical development for Asthma in Japan (Unknown route)
- 28 May 2001 Preclinical development for Inflammation in Japan (Unknown route)